MoneyWorks4Me

Auro Laboratories - Quaterly Results

25 May 2024 Evaluate
A decrease in the sales to Rs. 120.63 millions was observed for the quarter ended March 2024. The sales stood at Rs. 135.25 millions during the similar quarter previous year.Net Profit recorded in the quarter ended March 2024 rise to 30.12% to Rs. 23.20  millions  compared to R. 17.83 millions in corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 28.08 millions from 29.71 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 120.63 135.25 -10.81 536.35 528.94 1.40 536.35 528.94 1.40
Other Income 3.99 6.19 -35.54 15.04 9.41 59.83 15.04 9.41 59.83
PBIDT 28.08 29.71 -5.49 121.74 53.34 128.23 121.74 53.34 128.23
Interest -3.25 1.34 -342.54 7.36 8.14 -9.58 7.36 8.14 -9.58
PBDT 31.33 28.37 10.43 114.38 45.20 153.05 114.38 45.20 153.05
Depreciation 2.82 3.04 -7.24 10.92 10.74 1.68 10.92 10.74 1.68
PBT 28.51 25.33 12.55 103.46 34.46 200.23 103.46 34.46 200.23
TAX 5.31 7.50 -29.20 25.54 10.04 154.38 25.54 10.04 154.38
Deferred Tax -1.87 0.03 -6333.33 -1.87 0.03 -6333.33 -1.87 0.03 -6333.33
PAT 23.20 17.83 30.12 77.92 24.42 219.08 77.92 24.42 219.08
Equity 62.32 62.32 0.00 62.32 62.32 0.00 62.32 62.32 0.00
PBIDTM(%) 23.28 21.97 5.97 22.70 10.08 125.08 22.70 10.08 125.08
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..